Alpa Laboratories appoints Diksha Jaswani as company secretary

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Alpa Laboratories appoints Ms. Diksha Jaswani as Company Secretary cum Compliance Officer
  • The appointment takes effect from September 17, 2026, following Board approval
  • Ms. Jaswani holds Membership No. A80495 with the Institute of Company Secretaries of India
  • She has no shareholding in the company and no disclosed relationships with directors
powered bylight_fuzz_icon
51194927

*this image is generated using AI for illustrative purposes only.

Alpa Laboratories Limited appointed Ms. Diksha Jaswani as its Company Secretary cum Compliance Officer effective September 17, 2026. The Board of Directors approved the move during a meeting held on the same date.

The appointment was made based on recommendations from the Nomination and Remuneration Committee. It complies with Regulation 6(1) and Regulation 30(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Para A of Part A of Schedule III.

Appointment Details

Ms. Jaswani holds Membership No. A80495 with the Institute of Company Secretaries of India. She is an associate member with extensive experience in company law, including ROC filings and annual regulatory processes.

Particulars Details
Name Ms. Diksha Jaswani
Designation Company Secretary cum Compliance Officer (KMP)
Date of Appointment September 17, 2026
Shareholding Nil
Relationship with Directors Not Applicable

The company disclosed that Ms. Jaswani holds no shares in Alpa Laboratories. There are no disclosed relationships between her and the existing directors. The term of appointment is listed as not applicable in the filing.

Historical Stock Returns for Alpa Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.42%-5.69%-7.20%+0.44%-36.97%+7.27%

How might Ms. Jaswani's specific expertise in ROC filings and regulatory processes impact Alpa Laboratories' compliance efficiency and risk management in the coming fiscal year?

Given the absence of a defined term for this Key Managerial Personnel appointment, what are the expectations regarding performance reviews and potential contract renewals?

Does this appointment signal any upcoming changes in Alpa Laboratories' corporate governance structure or strategic compliance initiatives?

Alpa Laboratories sets Sept 30 record date for 38th AGM

scanx
Reviewed by
Naman SScanX News Team
Key Highlights
  • Alpa Laboratories sets September 30, 2026 as the record date for its 38th AGM
  • The register of members will be closed from September 23 to September 30, 2026
  • The AGM will be held via video conference on September 30 at 2:00 pm
  • The disclosure complies with SEBI Listing Regulations and the Companies Act, 2013
powered bylight_fuzz_icon
50325832

*this image is generated using AI for illustrative purposes only.

Alpa Laboratories has set September 30, 2026 as the record date for its 38th Annual General Meeting. The company will hold the meeting via video conference on that date at 2:00 pm.

The register of members and share transfer books will remain closed from September 23, 2026 to September 30, 2026, both days inclusive. This closure is necessary to determine shareholders eligible to vote at the AGM.

Meeting Details

The meeting will be conducted through video conference or other audio-visual means in compliance with Ministry of Corporate Affairs and SEBI circulars. It will take place at the company’s registered office in Indore, Madhya Pradesh.

Event Date Time
Book Closure Start September 23, 2026 N/A
Book Closure End September 30, 2026 N/A
AGM Date September 30, 2026 2:00 pm

Regulatory Compliance

The intimation is issued pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mahendra Singh Chawla, Director, signed the communication dated September 7, 2026.

Historical Stock Returns for Alpa Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
-2.42%-5.69%-7.20%+0.44%-36.97%+7.27%

What key financial results or strategic initiatives are expected to be presented at Alpa Laboratories' 38th AGM?

How might the upcoming board resolutions impact the company's dividend policy or capital allocation strategy for the next fiscal year?

Are there any anticipated changes in the company's leadership structure or director appointments to be voted on during the meeting?

More News on Alpa Laboratories

1 Year Returns:-36.97%